<\/p>\n

We are ready to support you in\u00a0Strategy, Marketing, Systematic International Company Partner Identification, Commercial Due Diligence, Business Development, Acquisition Search, Regulatory\u00a0projects,\u00a0and more in order to ensure your growth.<\/p>\n<\/div>\n<\/div>\n

[\/et_pb_cta][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"

Vietnam Featured image: Hanoi\u2019s Panorama & Skyline Gallery\u00a0 by Nguy\u1ec5n Ch\u00ed Thanh \u2013 Vu Long \u2013 2013 with\u00a0CC Vietnam: The growing OTC and Prescription Drugs market in South East Asia\u00a0 Vietnam\u2019s OTC and Prescription Drugs market is one of the fastest-growing markets in South-East Asia and is expected to continue growing in the next few […]<\/p>\n","protected":false},"author":7,"featured_media":0,"parent":8782,"menu_order":57,"comment_status":"open","ping_status":"open","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"[caption id=\"attachment_899\" align=\"alignleft\" width=\"300\"] $\"Vietnam\"$ Vietnam<\/a> by M M<\/a> with CC<\/a>[\/caption]\r\n\r\nViet\u00adnam is one of the most promis\u00ading phar\u00adma\u00adceu\u00adti\u00adcal mar\u00adkets in Asia.<\/strong> Cur\u00adrently worth almost US $3 billion, the Vietnamese healthcare market is esti\u00admated to see increases of as much as 17% per year in the near future. Ris\u00ading drug con\u00adsump\u00adtion and gov\u00adern\u00adment invest\u00adment contribute to the country\u2019s attrac\u00adtive OTC and Pharma mar\u00adket.\r\n\r\nIn 2012, there were approx\u00adi\u00admately 170 phar\u00adma\u00adceu\u00adti\u00adcal com\u00adpa\u00adnies and count\u00adless OTC, Med\u00adical Device and food sup\u00adple\u00adment com\u00adpa\u00adnies in Viet\u00adnam. Nearly 10% of these were owned by for\u00adeign investors, with an addi\u00adtional 4% oper\u00adat\u00ading under joint ven\u00adture agree\u00adments. Local phar\u00adma\u00adceu\u00adti\u00adcal pro\u00adduc\u00adtion was esti\u00admated at nearly US $920 million and was able to meet 48% of the nation\u2019s med\u00adical needs. Imported drugs accounted for the remain\u00ading <\/strong>52<\/strong>%.<\/strong>\r\n\r\nIn terms of mar\u00adket share, the largest drug com\u00adpa\u00adnies include Glax\u00ado\u00adSmithK\u00adline, Bris\u00adtol-Myers Squibb and Novar\u00adtis. Lead\u00ading Viet\u00adnamese com\u00adpa\u00adnies include Savipharm and Imex\u00adpharm. The biggest Health\u00adcare expen\u00addi\u00adture in Vietnam is in the out-of-pocket seg\u00adment, with national health insur\u00adance only cov\u00ader\u00ading a small sec\u00adtion of the pop\u00adu\u00adla\u00adtion and pri\u00advate expen\u00addi\u00adture accounting for around <\/strong>70<\/strong>% of spending.<\/strong> In terms of phar\u00admacy chains, there is one \u2018local giant\u2019, Phar\u00adma\u00adc\u00adity Jsc, which accounts for almost half of the share, the rest belong\u00ading to small, privately owned drugstores. Sta\u00adtis\u00adtics show that in terms of local man\u00adu\u00adfac\u00adtur\u00ading, there is an absence of nec\u00ades\u00adsary GMP facil\u00adi\u00adties. Many prod\u00aducts must be imported from abroad in order to sup\u00adple\u00adment the market\u2019s needs. The demand for essen\u00adtial imported med\u00adical drugs is much smaller, creating a big mar\u00adket space for for\u00adeign OTC and Rx com\u00adpa\u00adnies to suc\u00adcess\u00adfully mar\u00adket their prod\u00aducts in Viet\u00adnam.\r\n\r\nThe Drug Admin\u00adis\u00adtra\u00adtion of Viet\u00adnam is the country\u2019s phar\u00adma\u00adceu\u00adti\u00adcal prod\u00aduct reg\u00adu\u00adla\u00adtor, and the Depart\u00adment of Med\u00adical Equip\u00adment and Health Works is its Med\u00adical Device reg\u00adu\u00adla\u00adtor. All phar\u00adma\u00adceu\u00adti\u00adcals in Viet\u00adnam require both prod\u00aduct approval and a sep\u00ada\u00adrate import per\u00admit from the DAV. Only selected Med\u00adical Devices require approval for mar\u00adket\u00ading. The future out\u00adlook of Vietnam\u2019s phar\u00adma\u00adceu\u00adti\u00adcal indus\u00adtry is quite opti\u00admistic, as com\u00adpa\u00adnies in the coun\u00adtry are invest\u00ading huge amounts of money in Health\u00adcare. As the country\u2019s population continues to grow, development of the hos\u00adpi\u00adtal and healthcare sys\u00adtem has become a neces\u00adsity.\r\n\r\n[error] <\/strong>\r\n\r\nAs a fast-growing econ\u00adomy in Asia, Viet\u00adnam presents a tremen\u00addous oppor\u00adtu\u00adnity for for\u00adeign health\u00adcare \u00adfirms to estab\u00adlish them\u00adselves in a promis\u00ading Emerg\u00ading Mar\u00adket.<\/strong><\/span>\r\n\r\n[\/error]<\/strong>\r\n\r\n\r\n\r\n\r\n\r\n\r\n

CPC Press Releases on Vietnam:<\/strong><\/h3>\r\nThe great potential of the Vietnamese market<\/strong><\/a>","_et_gb_content_width":"","footnotes":"","_wp_rev_ctl_limit":""},"class_list":["post-8806","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.chameleon-pharma.com\/es\/wp-json\/wp\/v2\/pages\/8806","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.chameleon-pharma.com\/es\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.chameleon-pharma.com\/es\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.chameleon-pharma.com\/es\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/www.chameleon-pharma.com\/es\/wp-json\/wp\/v2\/comments?post=8806"}],"version-history":[{"count":14,"href":"https:\/\/www.chameleon-pharma.com\/es\/wp-json\/wp\/v2\/pages\/8806\/revisions"}],"predecessor-version":[{"id":17482,"href":"https:\/\/www.chameleon-pharma.com\/es\/wp-json\/wp\/v2\/pages\/8806\/revisions\/17482"}],"up":[{"embeddable":true,"href":"https:\/\/www.chameleon-pharma.com\/es\/wp-json\/wp\/v2\/pages\/8782"}],"wp:attachment":[{"href":"https:\/\/www.chameleon-pharma.com\/es\/wp-json\/wp\/v2\/media?parent=8806"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}